Drug details

Phenytek Extended Release Capsule (phenytoin sodium)

type of Anticonvulsants, Hydantoins, Antidysrhythmics, Ib

Phenytek (extended phenytoin sodium capsule) is an antiepileptic drug indicated for the control of generalized tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery.

This drug may have the following side effects:

• nausea,
• headache,
• dizziness,
• vomiting,
• rash, and
• constipation,
• tremor,
• nervousness,
• confusion, 
• trouble sleeping,
• slurred speech, 
• problems with walking and coordination,
• thinning bones (osteoporosis).

The following drugs are related to Phenytek Extended Release Capsule, either as a replacement or used together:

• Zyban (bupropion hcl)
• Wellbutrin (bupropion hcl)
• Wellbutrin XL (bupropion hydrochloride extended-release)
• Wellbutrin SR (bupropion hydrochloride sustained-release)
• Celontin (methsuximide)
• Depakote ER (divalproex sodium)
• Depakote Sprinkle Capsules (divalproex sodium sprinkle capsules)
• Valtoco (diazepam nasal spray)
• Dilantin (phenytoin)
• Dilantin 125 (phenytoin oral suspension)
• Dilantin Infatabs (phenytoin tablets)
• Dilantin Kapseals (extended phenytoin sodium capsules)
• Zarontin (ethosuximide)
• Zarontin Oral Solution (ethosuximide oral solution)
• Peganone (ethotoin)
• Felbatol (felbamate)
• Gabitril (tiagabine hydrochloride)
• Hyftor (sirolimus)
• Seizalam (midazolam for injection)